Saira Bates, MBA, Co-founder & CEO
Saira is a creative, dynamic and goal oriented leader with a unique combination of technical and business expertise. She has in-depth experience in drug development and drug delivery technologies. She has provided preclinical support to several oncology programs, two of which have resulted in marketed products, Treanda® and Synribo®. Saira has proven ability in business development and marketing. She founded and managed an oncology pharmaceutical company, Oncopharmaceuticals, and built a strong patent portfolio. Saira has ten issued and pending US patent applications. She has published her work in peer reviewed journals and presented at numerous scientific conferences. She has a BS in Biochemistry from Stony Brook University and pursued post graduate studies at University of Pennsylvania and UC Berkeley. She has a MBA from Pepperdine University.
Shawnya Michaels, MS, MBA, Co-founder & VP, Scientific Affairs
Shawnya is a skilled professional with over 20 years of drug development and cancer research experience. As a founding member of ChemGenex Pharmaceuticals, Shawnya developed and implemented an Oncology Discovery Research Program that resulted in > 20 presentations at national and international cancer conferences, the filing of INDs for two agents and eventually an NDA. In addition to early drug discovery and development activities, Shawnya developed and implemented a Medical Science Liaison program to gain company visibility and support among key opinion leaders in the field of hematologic oncology for pre-launch activities. Shawnya also coordinated and integrated the intellectual property assets at ChemGenex through patent filings and prosecutions for patent applications in the oncology field resulting in 20 US patent applications and 5 issued patents. Shawnya has seven issued and pending US patent applications. She has a BA in Neurobiology from UC Berkeley, an MS in Biotechnology Management and an MBA from University of Maryland University College (UMUC).